Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$507K Buy
1,866
+48
+3% +$10.2K ﹤0.01% 980
2026
Q1
$364K Sell
1,818
-360
-17% -$77.5K ﹤0.01% 1083
2025
Q4
$499K Buy
+2,178
New +$454K ﹤0.01% 946
2021
Q2
Sell
-14,332
Closed -$1.46M 1303
2021
Q1
$1.46M Buy
14,332
+215
+2% +$23.6K 0.01% 591
2020
Q4
$1.4M Buy
14,117
+5,196
+58% +$434K 0.01% 584
2020
Q3
$644K Buy
8,921
+3,475
+64% +$198K ﹤0.01% 719
2020
Q2
$271K Buy
5,446
+1,167
+27% +$46.9K ﹤0.01% 938
2020
Q1
$144K Hold
4,279
﹤0.01% 1303
2019
Q4
$144K Buy
4,279
+194
+5% +$7.15K ﹤0.01% 1303
2019
Q3
$133K Buy
4,085
+80
+2% +$2.37K ﹤0.01% 1310
2019
Q2
$110K Buy
+4,005
New +$88.4K ﹤0.01% 1362

Other funds holding NTRA

Glenmede Trust's NTRA Position: Q2 2026 in Review

Glenmede Trust increased its Natera (NTRA) stake by 2.6% in Q2 2026, buying an estimated $10.2K and bringing the position to 1,866 shares worth $507K. The position accounts for ﹤0.01% of the portfolio, ranked #980.

Glenmede Trust first reported a position in NTRA in Q2 2019 and has held it in 11 quarters since. The position peaked at $1.46M in Q1 2021. 847 funds tracked by Wall St. Rank hold NTRA as of Q2 2026.

  • Glenmede Trust held 1,866 shares of Natera worth $507K as of Q2 2026.
  • Glenmede Trust bought 48 Natera shares in Q2 2026, an estimated $10.2K.
  • Natera made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #980 holding.
  • Glenmede Trust first reported a position in Natera in Q2 2019 and has held it in 11 quarters since.
  • Glenmede Trust's Natera position peaked at $1.46M in Q1 2021.
  • 847 funds tracked by Wall St. Rank held Natera as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.